id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0001-0159,FDA,FDA-2012-N-0001,Fecal Microbiota for Transplantation Public Workshop,Notice,Meeting,2013-02-25T05:00:00Z,2013,2,2013-02-25T05:00:00Z,,2013-02-25T15:11:24Z,2013-04232,0,0,090000648120676c
FDA-2012-N-0001-0158,FDA,FDA-2012-N-0001,Vaccines and Related Biological Products Advisory Committee; Notice of Meeting,Notice,Meeting,2013-01-25T05:00:00Z,2013,1,,,2013-01-25T14:58:04Z,2013-01561,0,0,09000064811d7cb3
FDA-2012-N-0001-0156,FDA,FDA-2012-N-0001,Medical Imaging Drugs Advisory Committee Meeting,Notice,Meeting,2013-01-04T05:00:00Z,2013,1,2013-01-04T05:00:00Z,,2013-01-04T14:44:44Z,2012-31676,0,0,09000064811a802d
FDA-2012-N-0001-0157,FDA,FDA-2012-N-0001,Advisory Committee for Reproductive Health Drugs Meeting,Notice,Meeting,2013-01-04T05:00:00Z,2013,1,2013-01-04T05:00:00Z,,2013-01-04T14:48:03Z,2012-31675,0,0,09000064811a7f6d
FDA-2012-N-0001-0155,FDA,FDA-2012-N-0001,Advisory Committees; 2013 Tentative Schedule Meeting,Notice,Meeting,2013-01-02T05:00:00Z,2013,1,2013-01-02T05:00:00Z,,2013-01-03T13:07:07Z,2012-31475,0,0,09000064811a1f8d
FDA-2012-N-0001-0153,FDA,FDA-2012-N-0001,Public Workshops: Minimal Residual Disease,Notice,Meeting,2012-12-26T05:00:00Z,2012,12,2012-12-26T05:00:00Z,,2012-12-26T16:07:03Z,2012-31043,0,0,090000648119a540
FDA-2012-N-0001-0154,FDA,FDA-2012-N-0001,Public Workshops on Minimal Residual Disease,Notice,Meeting,2012-12-26T05:00:00Z,2012,12,2012-12-26T05:00:00Z,,2012-12-26T16:13:42Z,2012-31044,0,0,090000648119a75b
FDA-2012-N-0001-0151,FDA,FDA-2012-N-0001,Pulmonary-Allergy Drugs Advisory Committee,Notice,Meeting,2012-12-14T05:00:00Z,2012,12,2012-12-14T05:00:00Z,,2012-12-14T14:00:46Z,2012-30171,0,0,090000648118c473
FDA-2012-N-0001-0150,FDA,FDA-2012-N-0001,Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Correction,Notice,Correction,2012-12-13T05:00:00Z,2012,12,2012-12-13T05:00:00Z,,2012-12-13T18:54:38Z,2012-30024,0,0,090000648118b131
FDA-2012-N-0001-0149,FDA,FDA-2012-N-0001,"Cellular, Tissue, and Gene Therapies Advisory Committee Meeting",Notice,Meeting,2012-12-10T05:00:00Z,2012,12,2012-12-10T05:00:00Z,,2012-12-10T14:45:28Z,2012-29706,0,0,090000648118457e
FDA-2012-N-0001-0148,FDA,FDA-2012-N-0001,Endocrinologic and Metabolic Drugs Advisory Committee Meeting,Notice,Meeting,2012-12-10T05:00:00Z,2012,12,2012-12-10T05:00:00Z,,2012-12-10T14:41:31Z,2012-29650,0,0,0900006481184647
FDA-2012-N-0001-0147,FDA,FDA-2012-N-0001,Neurological Devices Panel of Medical Devices Advisory Committee Meeting,Notice,Meeting,2012-12-07T05:00:00Z,2012,12,2012-12-07T05:00:00Z,,2012-12-07T16:25:14Z,2012-29538,0,0,09000064811824e2
FDA-2012-N-0001-0146,FDA,FDA-2012-N-0001,Requests for Nominations: Nonvoting Industry Representatives on Public Advisory Panels,Notice,General Notice,2012-12-07T05:00:00Z,2012,12,2012-12-07T05:00:00Z,,2012-12-07T16:19:35Z,2012-29574,0,0,090000648118242a
FDA-2012-N-0001-0145,FDA,FDA-2012-N-0001,Requests for Nominations: Nonvoting Industry Representatives on the Device Good Manufacturing Practice Advisory Committee,Notice,General Notice,2012-12-04T05:00:00Z,2012,12,2012-12-04T05:00:00Z,,2012-12-04T16:34:39Z,2012-29165,0,0,090000648117e51c
FDA-2012-N-0001-0144,FDA,FDA-2012-N-0001,Orthopaedic and Rehabilitation Devices Panel of Medical Devices Advisory Committee Meeting,Notice,Meeting,2012-11-29T05:00:00Z,2012,11,2012-11-29T05:00:00Z,,2012-11-29T13:58:43Z,2012-28855,0,0,09000064811773aa
FDA-2012-N-0001-0143,FDA,FDA-2012-N-0001,Risk Communication Advisory Committee Meeting,Notice,Meeting,2012-11-26T05:00:00Z,2012,11,2012-11-26T05:00:00Z,,2012-11-26T14:57:34Z,2012-28462,0,0,09000064811730ba
FDA-2012-N-0001-0141,FDA,FDA-2012-N-0001,Pulmonary-Allergy Drugs Advisory Committee Meeting,Notice,Meeting,2012-11-20T05:00:00Z,2012,11,2012-11-20T05:00:00Z,,2012-11-20T14:27:36Z,2012-28205,0,0,090000648116e919
FDA-2012-N-0001-0142,FDA,FDA-2012-N-0001,Pulmonary-Allergy Drugs Advisory Committee Meeting,Notice,Meeting,2012-11-20T05:00:00Z,2012,11,2012-11-20T05:00:00Z,,2012-11-20T14:35:46Z,2012-28201,0,0,090000648116ebd5
FDA-2012-N-0001-0140,FDA,FDA-2012-N-0001,Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,Meeting,2012-11-16T05:00:00Z,2012,11,2012-11-16T05:00:00Z,,2012-11-16T15:08:09Z,2012-27934,0,0,0900006481168f6e
FDA-2012-N-0001-0139,FDA,FDA-2012-N-0001,Anesthetic and Analgesic Drug Products Advisory Committee Meeting,Notice,Meeting,2012-11-09T05:00:00Z,2012,11,2012-11-09T05:00:00Z,,2012-11-09T14:56:58Z,2012-27368,0,0,0900006481163fd8
FDA-2012-N-0001-0138,FDA,FDA-2012-N-0001,Blood Products Advisory Committee Meeting,Notice,Meeting,2012-11-08T05:00:00Z,2012,11,2012-11-08T05:00:00Z,,2012-11-08T15:21:39Z,2012-27323,0,0,0900006481162a70
FDA-2012-N-0001-0137,FDA,FDA-2012-N-0001,Circulatory System Devices Panel of Medical Devices Advisory Committee Notice of Meeting,Notice,Meeting,2012-11-07T05:00:00Z,2012,11,2012-11-07T05:00:00Z,,2012-11-24T03:00:49Z,2012-27068,0,0,09000064811613f0
FDA-2012-N-0001-0136,FDA,FDA-2012-N-0001,Burkholderia; Exploring Current Issues and Identifying Regulatory Science Gaps,Notice,Meeting,2012-11-07T05:00:00Z,2012,11,2012-11-07T05:00:00Z,,2012-11-07T14:29:08Z,2012-27146,0,0,09000064811613ec
FDA-2012-N-0001-0135,FDA,FDA-2012-N-0001,"Cellular, Tissue and Gene Therapies Advisory Committee Meeting",Notice,General Notice,2012-10-30T04:00:00Z,2012,10,2012-10-30T04:00:00Z,,2012-10-31T12:22:12Z,2012-26635,0,0,09000064811552e6
FDA-2012-N-0001-0134,FDA,FDA-2012-N-0001,Drug Safety and Risk Management Advisory Committee Meeting,Notice,Meeting,2012-10-24T04:00:00Z,2012,10,2012-10-24T04:00:00Z,,2012-10-24T13:35:31Z,2012-26162,0,0,090000648114e4d3
FDA-2012-N-0001-0133,FDA,FDA-2012-N-0001,Arthritis Advisory Committee Meeting,Notice,Meeting,2012-10-22T04:00:00Z,2012,10,2012-10-22T04:00:00Z,,2012-10-22T13:14:58Z,2012-25878,0,0,090000648114a87b
FDA-2012-N-0001-0132,FDA,FDA-2012-N-0001,Nonprescription Drugs Advisory Committee Meeting,Notice,Meeting,2012-10-19T04:00:00Z,2012,10,2012-10-19T04:00:00Z,,2012-10-19T13:05:22Z,2012-25788,0,0,0900006481148730
FDA-2012-N-0001-0131,FDA,FDA-2012-N-0001,Endocrinologic and Metabolic Drugs Advisory Committee Meeting,Notice,Meeting,2012-10-19T04:00:00Z,2012,10,2012-10-19T04:00:00Z,,2012-10-19T13:01:02Z,2012-25741,0,0,090000648114866d
FDA-2012-N-0001-0127,FDA,FDA-2012-N-0001,Oncologic Drugs Advisory Committee; Cancellation,Notice,General Notice,2012-10-17T04:00:00Z,2012,10,2012-10-17T04:00:00Z,,2012-10-17T14:01:51Z,2012-25503,0,0,0900006481144889
FDA-2012-N-0001-0130,FDA,FDA-2012-N-0001,"Cellular, Tissue and Gene Therapies Advisory Committee Meeting",Notice,Meeting,2012-10-17T04:00:00Z,2012,10,2012-10-17T04:00:00Z,,2012-10-17T14:11:57Z,2012-25482,0,0,0900006481144e34
FDA-2012-N-0001-0128,FDA,FDA-2012-N-0001,Vaccines and Related Biological Products Advisory Committee Meeting,Notice,Meeting,2012-10-17T04:00:00Z,2012,10,2012-10-17T04:00:00Z,,2012-10-17T14:05:36Z,2012-25484,0,0,0900006481144e7f
FDA-2012-N-0001-0129,FDA,FDA-2012-N-0001,Endocrinologic and Metabolic Drugs Advisory Committee Meeting,Notice,Meeting,2012-10-17T04:00:00Z,2012,10,2012-10-17T04:00:00Z,,2012-10-17T14:08:43Z,2012-25483,0,0,0900006481144e01
FDA-2012-N-0001-0126,FDA,FDA-2012-N-0001,Risk Communication Advisory Committee Meeting,Notice,Meeting,2012-10-12T04:00:00Z,2012,10,2012-10-12T04:00:00Z,,2012-10-12T13:02:07Z,2012-25101,0,0,090000648113e0b8
FDA-2012-N-0001-0125,FDA,FDA-2012-N-0001,Neurological Devices Panel of Medical Devices Advisory Committee Meeting,Notice,Meeting,2012-10-11T04:00:00Z,2012,10,2012-10-11T04:00:00Z,,2012-10-11T14:27:05Z,2012-24974,0,0,090000648113c16a
FDA-2012-N-0001-0124,FDA,FDA-2012-N-0001,Endocrinologic and Metabolic Drugs Advisory Committee,Notice,Meeting,2012-10-10T04:00:00Z,2012,10,2012-10-10T04:00:00Z,,2012-10-10T13:57:44Z,2012-24861,0,0,090000648113a16e
FDA-2012-N-0001-0123,FDA,FDA-2012-N-0001,Nominations: Voting Members on Public Advisory Committees,Notice,General Notice,2012-10-05T04:00:00Z,2012,10,2012-10-05T04:00:00Z,,2012-10-05T13:38:05Z,2012-24554,0,0,0900006481135b40
FDA-2012-N-0001-0121,FDA,FDA-2012-N-0001,"Requests for Nominations: Voting Members, Tobacco Products Scientific Advisory Committee",Notice,General Notice,2012-10-05T04:00:00Z,2012,10,2012-10-05T04:00:00Z,,2012-10-05T13:18:34Z,2012-24476,0,0,0900006481135989
FDA-2012-N-0001-0122,FDA,FDA-2012-N-0001,Request for Notification from Industry Organizations Interested in Participating in the Selection Process: Nonvoting Industry Representatives and Request for Nominations for Nonvoting Industry Representatives on the Tobacco Products Scientific Advisory Committee,Notice,General Notice,2012-10-05T04:00:00Z,2012,10,2012-10-05T04:00:00Z,,2012-10-05T13:22:24Z,2012-24560,0,0,09000064811359cb
FDA-2012-N-0001-0120,FDA,FDA-2012-N-0001,Clinical Investigator Training Course,Notice,General Notice,2012-10-03T04:00:00Z,2012,10,2012-10-03T04:00:00Z,,2012-10-03T13:18:05Z,2012-24214,0,0,0900006481132618
FDA-2012-N-0001-0119,FDA,FDA-2012-N-0001,Gastrointestinal Drugs Advisory Committee Meeting,Notice,General Notice,2012-09-28T04:00:00Z,2012,9,2012-09-28T04:00:00Z,,2012-09-28T13:04:40Z,2012-23885,0,0,090000648112c98b
FDA-2012-N-0001-0118,FDA,FDA-2012-N-0001,Public Workshops: Food Defense,Notice,Meeting,2012-09-27T04:00:00Z,2012,9,2012-09-27T04:00:00Z,,2012-09-27T13:31:12Z,2012-23778,0,0,090000648112abd2
FDA-2012-N-0001-0117,FDA,FDA-2012-N-0001,Anti-Infective Drugs Advisory Committee Meeting,Notice,Meeting,2012-09-26T04:00:00Z,2012,9,2012-09-26T04:00:00Z,,2012-09-26T13:39:46Z,2012-23573,0,0,090000648112899c
FDA-2012-N-0001-0116,FDA,FDA-2012-N-0001,Oncologic Drugs Advisory Committee,Notice,Meeting,2012-09-20T04:00:00Z,2012,9,,,2012-09-20T13:30:37Z,2012-23186,0,0,090000648111ffe1
FDA-2012-N-0001-0115,FDA,FDA-2012-N-0001,Anti-Infective Drugs Advisory Committee,Notice,Meeting,2012-09-20T04:00:00Z,2012,9,,,2012-09-20T13:21:41Z,2012-23185,0,0,090000648111fe63
FDA-2012-N-0001-0113,FDA,FDA-2012-N-0001,Science Advisory Board to the National Center for Toxicological Research Meeting,Notice,Meeting,2012-09-18T04:00:00Z,2012,9,2012-09-18T04:00:00Z,,2012-09-18T14:22:02Z,2012-22918,0,0,090000648111b57e
FDA-2012-N-0001-0114,FDA,FDA-2012-N-0001,Requests for Nonvoting Industry Representatives: Transmissible Spongiform Encephalopathies Advisory Committee,Notice,General Notice,2012-09-18T04:00:00Z,2012,9,2012-09-18T04:00:00Z,,2012-09-18T14:25:40Z,2012-22866,0,0,090000648111b661
FDA-2012-N-0001-0112,FDA,FDA-2012-N-0001,Pediatric Oncology Subcommittee of Oncologic Drugs Advisory Committee Meeting,Notice,Meeting,2012-09-17T04:00:00Z,2012,9,2012-09-17T04:00:00Z,,2012-09-17T15:05:46Z,,0,0,090000648111986b
FDA-2012-N-0001-0111,FDA,FDA-2012-N-0001,"Food and Drug Administration/American Glaucoma Society Workshop on Validity, Reliability, and Usability of Glaucoma Imaging Devices Workshop",Notice,Meeting,2012-09-13T04:00:00Z,2012,9,2012-09-13T04:00:00Z,,2012-12-14T17:43:14Z,2012-22518,0,0,0900006481114c75
FDA-2012-N-0001-0109,FDA,FDA-2012-N-0001,Anti-Infective Drugs Advisory Committee Meeting,Notice,Meeting,2012-09-11T04:00:00Z,2012,9,2012-09-11T04:00:00Z,,2012-09-11T15:02:51Z,2012-22208,0,0,0900006481110f5d
FDA-2012-N-0001-0110,FDA,FDA-2012-N-0001,Requests for Nominations: Science Board to Food and Drug Administration,Notice,Meeting,2012-09-11T04:00:00Z,2012,9,2012-09-11T04:00:00Z,,2012-09-11T15:07:42Z,2012-22210,0,0,09000064811110a3
FDA-2012-N-0001-0108,FDA,FDA-2012-N-0001,Nonprescription Drugs Advisory Committee Meeting,Notice,Meeting,2012-08-30T04:00:00Z,2012,8,2012-08-30T04:00:00Z,,2012-08-30T15:08:10Z,2012-21425,0,0,09000064810fb127
FDA-2012-N-0001-0107,FDA,FDA-2012-N-0001,Orphan Product Designation and Grant Workshop Meeting,Notice,Meeting,2012-08-30T04:00:00Z,2012,8,2012-08-30T04:00:00Z,,2012-08-30T14:29:52Z,2012-21398,0,0,09000064810faf62
FDA-2012-N-0001-0106,FDA,FDA-2012-N-0001,Science Board Meeting,Notice,Meeting,2012-08-23T04:00:00Z,2012,8,2012-08-23T04:00:00Z,,2012-08-23T15:13:39Z,2012-20782,0,0,09000064810ec509
FDA-2012-N-0001-0105,FDA,FDA-2012-N-0001,Cardiovascular and Renal Drugs Advisory Committee Meeting; Cancellation,Notice,General Notice,2012-08-22T04:00:00Z,2012,8,2012-08-22T04:00:00Z,,2012-08-22T14:17:15Z,2012-20607,0,0,09000064810e999a
FDA-2012-N-0001-0104,FDA,FDA-2012-N-0001,Radiological Devices Panel of Medical Devices Advisory Committee Meeting,Notice,Meeting,2012-08-22T04:00:00Z,2012,8,2012-08-22T04:00:00Z,,2012-08-22T14:13:00Z,2012-20608,0,0,09000064810e9b52
FDA-2012-N-0001-0103,FDA,FDA-2012-N-0001,Gastrointestinal Drugs Advisory Committee Meeting,Notice,Meeting,2012-08-22T04:00:00Z,2012,8,2012-08-22T04:00:00Z,,2012-08-22T14:08:31Z,2012-20612,0,0,09000064810e99da
FDA-2012-N-0001-0098,FDA,FDA-2012-N-0001,Endocrinologic and Metabolic Drugs Advisory Committee Meeting,Notice,Meeting,2012-08-16T04:00:00Z,2012,8,2012-08-16T04:00:00Z,,2012-08-16T14:12:05Z,2012-20104,0,0,09000064810de82d
FDA-2012-N-0001-0097,FDA,FDA-2012-N-0001,Meetings: Gastrointestinal Drugs Advisory Committee,Notice,Meeting,2012-08-16T04:00:00Z,2012,8,2012-08-16T04:00:00Z,,2012-08-16T14:33:55Z,2012-20103,0,0,09000064810de6e2
FDA-2012-N-0001-0100,FDA,FDA-2012-N-0001,Design of Clinical Trials of Antibacterial Drugs for the Treatment of Non-Cystic Fibrosis Bronchiectasis Public Workshop,Notice,Meeting,2012-08-16T04:00:00Z,2012,8,2012-08-16T04:00:00Z,,2012-08-16T14:21:48Z,2012-20106,0,0,09000064810de7fa
FDA-2012-N-0001-0101,FDA,FDA-2012-N-0001,"Clinical Trial Requirements, Regulations, Compliance, and Good Clinical Practice Public Workshop",Notice,Meeting,2012-08-16T04:00:00Z,2012,8,2012-08-16T04:00:00Z,,2012-08-16T14:26:26Z,2012-19851,0,0,09000064810de732
FDA-2012-N-0001-0099,FDA,FDA-2012-N-0001,Endpoints for Clinical Trials in Kidney Transplantation Meeting,Notice,Meeting,2012-08-16T04:00:00Z,2012,8,2012-08-16T04:00:00Z,,2012-08-16T14:16:32Z,2012-20105,0,0,09000064810de7c5
FDA-2012-N-0001-0102,FDA,FDA-2012-N-0001,"Clinical Trial Requirements, Regulations, Compliance, and Good Clinical Practice Public Workshop",Notice,Meeting,2012-08-16T04:00:00Z,2012,8,2012-08-16T04:00:00Z,,2012-08-16T14:30:32Z,2012-19852,0,0,09000064810de82b
FDA-2012-N-0001-0096,FDA,FDA-2012-N-0001,Endocrinologic and Metabolic Drugs Advisory Committee Meeting,Notice,Meeting,2012-08-15T04:00:00Z,2012,8,2012-08-15T04:00:00Z,,2012-08-15T13:33:24Z,2012-20013,0,0,09000064810daba5
FDA-2012-N-0001-0095,FDA,FDA-2012-N-0001,Second Annual Health Professional Organizations Conference,Notice,Meeting,2012-08-09T04:00:00Z,2012,8,2012-08-09T04:00:00Z,,2012-08-09T14:19:10Z,2012-19549,0,0,09000064810ca292
FDA-2012-N-0001-0094,FDA,FDA-2012-N-0001,Compliance Through Quality Systems; Implementing and Advancing Sustainable Global Quality Culture Public Conference,Notice,Meeting,2012-08-07T04:00:00Z,2012,8,2012-08-07T04:00:00Z,,2012-08-07T13:00:05Z,2012-19295,0,0,09000064810c46bb
FDA-2012-N-0001-0093,FDA,FDA-2012-N-0001,Gastroenterology Regulatory Endpoints and the Advancement of Therapeuticss (GREAT); Public Workshop,Notice,Meeting,2012-08-03T04:00:00Z,2012,8,,,2012-10-22T15:54:09Z,2012-19036,0,0,09000064810c0a6d
FDA-2012-N-0001-0092,FDA,FDA-2012-N-0001,Statistical Process Controls for Blood Establishments: Workshop,Notice,Meeting,2012-08-02T04:00:00Z,2012,8,2012-08-02T04:00:00Z,,2012-08-02T14:41:06Z,2012-18854,0,0,09000064810bee6c
FDA-2012-N-0001-0091,FDA,FDA-2012-N-0001,Meetings: Blood Products Advisory Committee,Notice,Meeting,2012-08-01T04:00:00Z,2012,8,2012-08-01T04:00:00Z,,2012-08-01T16:42:48Z,2012-18724,0,0,09000064810bc32d
FDA-2012-N-0001-0090,FDA,FDA-2012-N-0001,Pediatric Advisory Committee Meeting,Notice,Meeting,2012-07-30T04:00:00Z,2012,7,2012-07-30T04:00:00Z,,2012-07-30T13:35:04Z,2012-18509,0,0,09000064810b74fd
FDA-2012-N-0001-0088,FDA,FDA-2012-N-0001,Food and Drug Administration Pediatric Medical Devices; Notice of Workshop,Notice,Meeting,2012-07-26T04:00:00Z,2012,7,,,2012-07-26T13:26:42Z,2012-18231,0,0,09000064810b1b00
FDA-2012-N-0001-0089,FDA,FDA-2012-N-0001,Risks and Benefits of Hydroxyethyl Starch Solutions: Public Workshops,Notice,Meeting,2012-07-25T04:00:00Z,2012,7,,,2012-07-27T13:16:00Z,2012-18110,0,0,09000064810aeff2
FDA-2012-N-0001-0087,FDA,FDA-2012-N-0001,Cardiovascular and Renal Drugs Advisory Committee: Meetings,Notice,Meeting,2012-07-25T04:00:00Z,2012,7,,,2012-07-25T13:59:36Z,2012-18095,0,0,09000064810aee12
FDA-2012-N-0001-0086,FDA,FDA-2012-N-0001,Meetings: Cardiovascular and Renal Drugs Advisory Committee,Notice,Meeting,2012-07-23T04:00:00Z,2012,7,2012-07-23T04:00:00Z,,2012-07-23T13:38:32Z,2012-17881,0,0,09000064810a9b91
FDA-2012-N-0001-0085,FDA,FDA-2012-N-0001,Advisory Committee for Pharmaceutical Science and Clinical Pharmacology Meeting,Notice,Meeting,2012-07-20T04:00:00Z,2012,7,2012-07-20T04:00:00Z,,2012-07-20T15:11:29Z,2012-17667,0,0,09000064810a6fa5
FDA-2012-N-0001-0084,FDA,FDA-2012-N-0001,Ophthalmic Devices Panel of the Medical Devices Advisory Committee: Notice of Meeting,Notice,Meeting,2012-07-19T04:00:00Z,2012,7,,,2012-07-19T13:01:10Z,2012-17668,0,0,09000064810a4312
FDA-2012-N-0001-0082,FDA,FDA-2012-N-0001,Meetings: Orthopaedic and Rehabilitation Devices Panel of Medical Devices Advisory Committee,Notice,Meeting,2012-07-18T04:00:00Z,2012,7,2012-07-18T04:00:00Z,,2012-07-18T16:31:37Z,2012-17431,0,0,090000648109fa55
FDA-2012-N-0001-0083,FDA,FDA-2012-N-0001,Meetings: Vaccines and Related Biological Products Advisory Committee,Notice,Meeting,2012-07-18T04:00:00Z,2012,7,2012-07-18T04:00:00Z,,2012-07-18T16:35:41Z,2012-17482,0,0,090000648109fa5c
FDA-2012-N-0001-0081,FDA,FDA-2012-N-0001,Use of Influenza Disease Models to Quantitatively Evaluate the Benefits and Risks of Vaccines Public Workshop,Notice,Meeting,2012-07-17T04:00:00Z,2012,7,2012-07-17T04:00:00Z,,2012-07-17T13:05:07Z,2012-17337,0,0,090000648109dad1
FDA-2012-N-0001-0080,FDA,FDA-2012-N-0001,Advisory Committee for Pharmaceutical Science and Clinical Pharmacology Meeting,Notice,Meeting,2012-07-16T04:00:00Z,2012,7,2012-07-16T04:00:00Z,,2012-07-16T14:30:28Z,2012-17193,0,0,090000648109bc8b
FDA-2012-N-0001-0079,FDA,FDA-2012-N-0001,"FDA, Xavier University Global Outsourcing Conference",Notice,General Notice,2012-07-13T04:00:00Z,2012,7,,,2012-07-13T13:48:56Z,2012-17077,0,0,0900006481093388
FDA-2012-N-0001-0078,FDA,FDA-2012-N-0001,Anti-Infective Drugs Advisory Committee Meeting,Notice,Meeting,2012-07-10T04:00:00Z,2012,7,2012-07-10T04:00:00Z,,2012-07-10T13:25:02Z,2012-16811,0,0,090000648108244f
FDA-2012-N-0001-0077,FDA,FDA-2012-N-0001,Oncologic Drugs Advisory Committee; Amendment,Notice,General Notice,2012-06-25T04:00:00Z,2012,6,2012-06-25T04:00:00Z,,2012-06-25T13:08:30Z,2012-15393,0,0,0900006481063988
FDA-2012-N-0001-0076,FDA,FDA-2012-N-0001,Gastrointestinal Drugs Advisory Committee Notice of Meeting,Notice,Meeting,2012-06-21T04:00:00Z,2012,6,,,2012-06-21T17:07:29Z,2012-15131,0,0,090000648105c8a3
FDA-2012-N-0001-0075,FDA,FDA-2012-N-0001,Dermatologic and Ophthalmic Drugs Advisory Committee Meeting,Notice,Meeting,2012-06-19T04:00:00Z,2012,6,2012-06-19T04:00:00Z,,2012-06-19T13:29:06Z,2012-14814,0,0,09000064810548d2
FDA-2012-N-0001-0074,FDA,FDA-2012-N-0001,Update to Electronic Common Technical Document Module 1,Notice,Meeting,2012-06-14T04:00:00Z,2012,6,,,2012-06-14T15:56:36Z,2012-14469,0,0,0900006481049976
FDA-2012-N-0001-0073,FDA,FDA-2012-N-0001,Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee; Amendment of Notice,Notice,General Notice,2012-05-31T04:00:00Z,2012,5,,,2012-05-31T16:23:28Z,2012-13157,0,0,0900006481022cec
FDA-2012-N-0001-0072,FDA,FDA-2012-N-0001,Oncologic Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2012-05-31T04:00:00Z,2012,5,,,2012-05-31T14:12:04Z,2012-13156,0,0,0900006481022c2b
FDA-2012-N-0001-0071,FDA,FDA-2012-N-0001,Oncologic Drugs Advisory Committee: Notice of Meeting,Notice,Meeting,2012-05-24T04:00:00Z,2012,5,,,2012-05-24T16:15:27Z,2012-12588,0,0,090000648101b49c
FDA-2012-N-0001-0070,FDA,FDA-2012-N-0001,Use of Computer Simulation of the United States Blood Supply in Support of Planning for Emergency Preparedness and Medical Countermeasures: Public Workshops,Notice,Meeting,2012-05-24T04:00:00Z,2012,5,,,2012-05-24T15:59:58Z,2012-12593,0,0,090000648101b42d
FDA-2012-N-0001-0069,FDA,FDA-2012-N-0001,Requirements for Importing Food and Drug Administration Regulated Products Into the United States,Notice,Meeting,2012-05-24T04:00:00Z,2012,5,,,2012-05-24T15:54:41Z,2012-12592,0,0,090000648101b40a
FDA-2012-N-0001-0068,FDA,FDA-2012-N-0001,Risk Communication Advisory Committee; Notice of Meeting,Notice,Meeting,2012-05-24T04:00:00Z,2012,5,,,2012-05-24T15:56:54Z,2012-12587,0,0,090000648101b3c6
FDA-2012-N-0001-0067,FDA,FDA-2012-N-0001,Blood Products Advisory Committee; Notice of Meeting,Notice,Meeting,2012-05-18T04:00:00Z,2012,5,,,2012-05-18T12:44:04Z,2012-12164,0,0,0900006481013e38
FDA-2012-N-0001-0066,FDA,FDA-2012-N-0001,Gastrointestinal Drugs Advisory Committee Meeting; Cancellation,Notice,General Notice,2012-05-08T04:00:00Z,2012,5,2012-05-08T04:00:00Z,,2012-05-08T13:15:28Z,2012-10990,0,0,0900006481007f92
FDA-2012-N-0001-0064,FDA,FDA-2012-N-0001,"Redefining the C in CGMP:  Creating, Implementing, and Sustaining a Culture of Compliance Workshop",Notice,Meeting,2012-05-07T04:00:00Z,2012,5,2012-05-07T04:00:00Z,,2012-05-07T14:56:28Z,2012-10894,0,0,090000648100663e
FDA-2012-N-0001-0065,FDA,FDA-2012-N-0001,"Educational Forum on Medical Device Reporting, Complaint Files, and Recalls, Corrections, and Removals Workshop",Notice,Meeting,2012-05-07T04:00:00Z,2012,5,2012-05-07T04:00:00Z,,2012-05-07T14:53:33Z,2012-10893,0,0,090000648100625b
FDA-2012-N-0001-0063,FDA,FDA-2012-N-0001,Oncologic Drugs Advisory Committee Meeting,Notice,Meeting,2012-04-27T04:00:00Z,2012,4,2012-04-27T04:00:00Z,,2012-04-27T13:07:22Z,2012-10154,0,0,0900006480ffe4c2
FDA-2012-N-0001-0062,FDA,FDA-2012-N-0001,Circulatory System Devices Panel of Medical Devices Advisory Committee Meeting,Notice,Meeting,2012-04-27T04:00:00Z,2012,4,2012-04-27T04:00:00Z,,2012-04-27T13:03:28Z,2012-10156,0,0,0900006480ffeb51
FDA-2012-N-0001-0061,FDA,FDA-2012-N-0001,"The 15th Annual Food and Drug Administration-Orange County Regulatory Affairs Educational Conference in Irvine, CA; Sustainable Regulatory Practices",Notice,Meeting,2012-04-25T04:00:00Z,2012,4,2012-04-25T04:00:00Z,,2012-04-25T14:22:05Z,2012-09968,0,0,0900006480ffb026
FDA-2012-N-0001-0060,FDA,FDA-2012-N-0001,Food and Drug Administration Patient Network Annual Meeting; Input Into Food and Drug Administration Benefit-Risk Decisionmaking: Opportunities and Challenges; Hosted by the Food and Drug Administration Office of Special Health Issues; Notice of Meeting,Notice,Meeting,2012-04-19T04:00:00Z,2012,4,,,2012-04-19T14:16:48Z,2012-09418,0,0,0900006480ff40bf
FDA-2012-N-0001-0052,FDA,FDA-2012-N-0001,Cardiovascular and Renal Drugs Advisory Committee: Meetings,Notice,Meeting,2012-04-12T04:00:00Z,2012,4,,,2012-04-12T13:28:47Z,2012-08824,0,0,0900006480fee2f5